155 related articles for article (PubMed ID: 10569805)
1. Transforming activity of the RL-akt gene, a c-akt gene activated by long terminal repeat insertion in murine leukemia RL(male symbol)1 cells.
Tanino M; Matsuo M; Uenaka A; Tsukuda K; Ouchida M; Nakayama E; Shimizu K
Mol Carcinog; 1999 Dec; 26(4):286-97. PubMed ID: 10569805
[TBL] [Abstract][Full Text] [Related]
2. Rejection antigen peptides on BALB/c RL male 1 leukemia recognized by cytotoxic T lymphocytes: derivation from the normally untranslated 5' region of the c-akt proto-oncogene activated by long terminal repeat.
Wada H; Matsuo M; Uenaka A; Shimbara N; Shimizu K; Nakayama E
Cancer Res; 1995 Nov; 55(21):4780-3. PubMed ID: 7585504
[TBL] [Abstract][Full Text] [Related]
3. Rapamycin inhibits Akt-mediated oncogenic transformation and tumor growth.
Liu X; Powlas J; Shi Y; Oleksijew AX; Shoemaker AR; De Jong R; Oltersdorf T; Giranda VL; Luo Y
Anticancer Res; 2004; 24(5A):2697-704. PubMed ID: 15517874
[TBL] [Abstract][Full Text] [Related]
4. The proteins encoded by c-akt and v-akt differ in post-translational modification, subcellular localization and oncogenic potential.
Ahmed NN; Franke TF; Bellacosa A; Datta K; Gonzalez-Portal ME; Taguchi T; Testa JR; Tsichlis PN
Oncogene; 1993 Jul; 8(7):1957-63. PubMed ID: 8510938
[TBL] [Abstract][Full Text] [Related]
5. Rit, a non-lipid-modified Ras-related protein, transforms NIH3T3 cells without activating the ERK, JNK, p38 MAPK or PI3K/Akt pathways.
Rusyn EV; Reynolds ER; Shao H; Grana TM; Chan TO; Andres DA; Cox AD
Oncogene; 2000 Sep; 19(41):4685-94. PubMed ID: 11032018
[TBL] [Abstract][Full Text] [Related]
6. Bcl-x(L) and Akt cooperate to promote leukemogenesis in vivo.
Karnauskas R; Niu Q; Talapatra S; Plas DR; Greene ME; Crispino JD; Rudin CM
Oncogene; 2003 Feb; 22(5):688-98. PubMed ID: 12569361
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of avian or mouse c-jun in primary chick embryo fibroblasts confers a partially transformed phenotype.
Castellazzi M; Dangy JP; Mechta F; Hirai S; Yaniv M; Samarut J; Lassailly A; Brun G
Oncogene; 1990 Oct; 5(10):1541-7. PubMed ID: 2123532
[TBL] [Abstract][Full Text] [Related]
8. Identification of a transforming activity suppressing sequence in the c-raf oncogene.
Ishikawa F; Sakai R; Ochiai M; Takaku F; Sugimura T; Nagao M
Oncogene; 1988 Dec; 3(6):653-8. PubMed ID: 2577866
[TBL] [Abstract][Full Text] [Related]
9. Oncogenic activation of the tyrosine kinase domain of the human trk proto-oncogene by fusion to a cell adhesion molecule.
Albor A; Thraves PJ; Dritschilo A; Notario V
Oncogene; 1996 Oct; 13(8):1755-63. PubMed ID: 8895522
[TBL] [Abstract][Full Text] [Related]
10. Phosphatidylinositol 3-kinase (PI-3K)/Akt but not PI-3K/p70 S6 kinase signaling mediates IGF-1-promoted lens epithelial cell survival.
Chandrasekher G; Sailaja D
Invest Ophthalmol Vis Sci; 2004 Oct; 45(10):3577-88. PubMed ID: 15452065
[TBL] [Abstract][Full Text] [Related]
11. Oncogenic activation of murine mos protein kinase by DNA rearrangement of its N-terminal coding region.
Ohuchi T; Kurita Y; Sasai H; Miyoshi J; Nomura T; Toyoshima K
Oncogene; 1992 Feb; 7(2):331-8. PubMed ID: 1532243
[TBL] [Abstract][Full Text] [Related]
12. Identification of AKT-regulated genes in inducible MERAkt cells.
Kuhn I; Bartholdi MF; Salamon H; Feldman RI; Roth RA; Johnson PH
Physiol Genomics; 2001 Dec; 7(2):105-14. PubMed ID: 11773597
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of colony formation of NIH 3T3 cells by the expression of the small molecular weight heat shock protein HSP27: involvement of its phosphorylation and aggregation at the C-terminal region.
Arata S; Hamaguchi S; Nose K
J Cell Physiol; 1997 Jan; 170(1):19-26. PubMed ID: 9012781
[TBL] [Abstract][Full Text] [Related]
14. Overexpression confers an oncogenic potential upon the eph gene.
Maru Y; Hirai H; Takaku F
Oncogene; 1990 Mar; 5(3):445-7. PubMed ID: 2314900
[TBL] [Abstract][Full Text] [Related]
15. Expression of multiple unique rejection antigens on murine leukemia BALB/c RLmale symbol1 and the role of dominant Akt antigen for tumor escape.
Matsuo M; Wada H; Honda S; Tawara I; Uenaka A; Kanematsu T; Nakayama E
J Immunol; 1999 Jun; 162(11):6420-5. PubMed ID: 10352255
[TBL] [Abstract][Full Text] [Related]
16. Mouse fibroblasts transformed with the human c-myc gene express a high level of mRNA but a low level of c-myc protein and are non-tumorigenic in nude mice.
Ray R; Thomas S; Miller DM
Oncogene; 1989 May; 4(5):593-600. PubMed ID: 2657574
[TBL] [Abstract][Full Text] [Related]
17. Structure, expression and chromosomal mapping of c-akt: relationship to v-akt and its implications.
Bellacosa A; Franke TF; Gonzalez-Portal ME; Datta K; Taguchi T; Gardner J; Cheng JQ; Testa JR; Tsichlis PN
Oncogene; 1993 Mar; 8(3):745-54. PubMed ID: 8437858
[TBL] [Abstract][Full Text] [Related]
18. Protein kinase C-alpha overexpression stimulates Akt activity and suppresses apoptosis induced by interleukin 3 withdrawal.
Li W; Zhang J; Flechner L; Hyun T; Yam A; Franke TF; Pierce JH
Oncogene; 1999 Nov; 18(47):6564-72. PubMed ID: 10597260
[TBL] [Abstract][Full Text] [Related]
19. Silibinin protects against photocarcinogenesis via modulation of cell cycle regulators, mitogen-activated protein kinases, and Akt signaling.
Mallikarjuna G; Dhanalakshmi S; Singh RP; Agarwal C; Agarwal R
Cancer Res; 2004 Sep; 64(17):6349-56. PubMed ID: 15342425
[TBL] [Abstract][Full Text] [Related]
20. The mouse mammary tumor associated gene INT3 is a unique member of the NOTCH gene family (NOTCH4).
Gallahan D; Callahan R
Oncogene; 1997 Apr; 14(16):1883-90. PubMed ID: 9150355
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]